24,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
12 °P sammeln
  • Broschiertes Buch

It is important to evaluate the role of the IF2 within the bacterial translation regulatory mechanism as well as to pose the IF2 as a molecular target for repurposed non-steroidal anti-inflammatory drugs (NSAIDS). The aim of this project is to identify a novel and an effective therapeutic endogenous molecular target in Mycobacterium tuberculosis. In this study, I have identified, cloned, expressed and partially purified the novel putative endogenous therapeutic target for various non-steroidal anti-inflammatory drugs (NSAIDs) from H37Rv strain of Mycobacterium tuberculosis: putative…mehr

Produktbeschreibung
It is important to evaluate the role of the IF2 within the bacterial translation regulatory mechanism as well as to pose the IF2 as a molecular target for repurposed non-steroidal anti-inflammatory drugs (NSAIDS). The aim of this project is to identify a novel and an effective therapeutic endogenous molecular target in Mycobacterium tuberculosis. In this study, I have identified, cloned, expressed and partially purified the novel putative endogenous therapeutic target for various non-steroidal anti-inflammatory drugs (NSAIDs) from H37Rv strain of Mycobacterium tuberculosis: putative mycobacterial infB, Rv2839c encoded protein which is putative protein translation initiation factor 2 (IF2) in a few species of mycobacteria. I conclude it may lead us to the discovery of the new anti-tubercular role of some old inexpensive NSAIDs and/or their derivatives as effective drugs against IF2 of Mycobacterium tuberculosis.
Autorenporträt
Em 2013, formei-me no Birkbeck College, Universidade de Londres, no Reino Unido, com um diploma de dois anos em Microbiologia Clínica. O mais importante para mim foi a minha participação na clonagem, expressão heteróloga e purificação de alguns alvos moleculares putativos de medicamentos do Mycobacterium tuberculosis, com os quais obtive nota de mérito.